“The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients”, Genetics and Mol. Res., vol. 25, no. 1, pp. 1–25, Jan. 2026, doi: 10.4238/1fvw5h08.